Pharmaceutical composition for treating cerebral apoplexy and preparation method

Abstract

The invention discloses a pharmaceutical composition for treating cerebral apoplexy and a preparation method. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 20 to 80 parts of myrobalan, 20 to 80 parts of prepared kusnezoff monkshood root, 10 to 50 parts of acorus tatarinowii, 10 to 50 parts of costus root, 5 to 30 parts of clove, 10 to 50 parts of nutmeg, and 5 to 30 parts of artificial musk. Pharmacological experiments show that the pharmaceutical composition has a good effect of treating the cerebral apoplexy. The preparation method is simple.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating cerebral apoplexy. Background technique [0002] Cerebral apoplexy is also called cerebral apoplexy and cerebral infarction. The clinical manifestations are often hemiplegia, aphasia, crooked mouth and eyes, and even coma. Taking this as an analogy, it is called "stroke". After stroke patients get sick, they basically lose their ability to take care of themselves, which brings great pain to patients and their families. Stroke is caused by cerebrovascular disease. Because most of the onsets are relatively sudden, it is also called "cerebrovascular accident". Any disease that causes cerebral blood circulation disorder and brain tissue function or structural damage due to cerebrovascular obstruction or rupture can be called cerebral apoplexy, that is, the state of cerebral apoplexy. The dysfunction of the human body caused by a stroke is de...

AI Technical Summary

Problems solved by technology

[0003] The traditional Chinese medicines currently used clinically to treat cerebral infarction include refined Agkistrodon antithrombotic enzyme, Ligustrazine injection, compound Danshen injection, etc. The main purpose is to dissolve thrombus and relieve cerebral artery blockage. It can alleviate some symptoms of patients, but most of the patients with cerebral infarction are elderly people with deficiency of Qi and blood. Only a single application of thrombolytic drugs cannot fundamentally solve the patient's symptoms, and even lead to cerebral vascular hemorrhage, which aggravates the patient's condition

[0004] Because the brain has a blood-brain barrier, it is difficult for drugs to reach the patient's site when there is a brain disease, resulting in a greatly reduced efficacy. Therefore, in order to solve this problem, many medical workers are working hard to find an effective treatment for stroke medicine

Images